Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Drug Targets - Cardiovascular and Haematological Disorders
Current Drug Targets - Cardiovascular and Haematological Disorders is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1568-0061Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Current Drug Targets - Cardiovascular and Haematological Disorders indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2001–2005).
What is the impact factor of Current Drug Targets - Cardiovascular and Haematological Disorders?
Current Drug Targets - Cardiovascular and Haematological Disorders has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Current Drug Targets - Cardiovascular and Haematological Disorders and what is its ISSN?
Current Drug Targets - Cardiovascular and Haematological Disorders is published by Bentham Science Publishers. Its ISSN is 1568-0061.
Is Current Drug Targets - Cardiovascular and Haematological Disorders in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Current Drug Targets - Cardiovascular and Haematological Disorders open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Current Drug Targets - Cardiovascular and Haematological Disorders for 5 years, between 2001 and 2005. Coverage ended in 2005, 21 years ago, and Scopus now lists the title as inactive.
How well cited is Current Drug Targets - Cardiovascular and Haematological Disorders? — open metrics via OpenAlex
Current Drug Targets - Cardiovascular and Haematological Disorders has an h-index of 52 and a 2-year mean of 1.16 citations per paper (OpenAlex).
Current Drug Targets - Cardiovascular and Haematological Disorders published 42 papers in 2025; its busiest recent year was 2018 with 59. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Current Drug Targets - Cardiovascular and Haematological Disorders? — latest 95 articles, 2024–2026
In its latest 95 research articles (2024–2026), authors are most often from India (39.6%), United States (15.4%) and Iran (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Current Drug Targets - Cardiovascular and Haematological Disorders? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2005. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2005
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.